First selected as top 80 from the 4500 applications from companies all over the world aiming for innovative solutions to the sustainable goals of the UN Agenda 2030 to then win the wellbeing track sponsored by Loreal.
The event is exclusive for the selected top 100 companies in deep tech, globally. Ilya Pharma is in the wellbeing track and gets the opportunity to present for and meet with specially invited global pharma and biotech investors.
Advanced wound care has been identified by Redeye as segment attaining a strong interest for investments. Four growth stage companies have been invited to present at the Advanced Wound Care-seminar in Stockholm. Ilya Pharma, PROMORE, S2 MEDICAL and RLS GLOBAL, all within the AWC space in Medtech and Pharma.
Evelina Vågesjö pitching the company at the Nasdaq event. The five minutes pitch was followed by questions and answers from a specialised jury.
Evelina Vågesjö was presenting at Evonik HQ at an EIC Corporate Day, the 6th of February, in Essen Germany. Out of 4000 applicants sixteen companies were hand picked by Evonik to present their innovations and businesses. Ilya Pharma was one of the chosen companies.
A Postdoctoral Research Scientist position is available as part of a collaboration between Professor Mia Phillipson and Ilya Pharma AB aiming to develop novel therapeutics to treat inflammatory bowel disease.
Ilya Pharma raises additional Euro 3 million to take novel ATMP through to Phase II for wound care
A high-quality, pilot-scale biopharmaceutical manufacturing facility is now opening in Uppsala, Sweden. The new Testa Center at GE Healthcare is both a national and an international test bed for start-up companies working with technology- and biologics innovations, as well as for the bioprocess industry. Ilya Pharma will be one of the first companies to use the bioprocess equipment.